335 related articles for article (PubMed ID: 33837463)
1. Real-world evidence and product development: Opportunities, challenges and risk mitigation.
Naidoo P; Bouharati C; Rambiritch V; Jose N; Karamchand S; Chilton R; Leisegang R
Wien Klin Wochenschr; 2021 Aug; 133(15-16):840-846. PubMed ID: 33837463
[TBL] [Abstract][Full Text] [Related]
2. Real-World Evidence: A Primer.
Dang A
Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
[TBL] [Abstract][Full Text] [Related]
3. Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process.
Zisis K; Pavi E; Geitona M; Athanasakis K
J Pharm Pharm Sci; 2024; 27():12302. PubMed ID: 38481726
[No Abstract] [Full Text] [Related]
4. Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design.
Dagenais S; Russo L; Madsen A; Webster J; Becnel L
Clin Pharmacol Ther; 2022 Jan; 111(1):77-89. PubMed ID: 34839524
[TBL] [Abstract][Full Text] [Related]
5. Contemporary Databases in Real-world Studies Regarding the Diverse Health Care Systems of India, Thailand, and Taiwan: Protocol for a Scoping Review.
Shau WY; Setia S; Shinde SP; Santoso H; Furtner D
JMIR Res Protoc; 2022 Dec; 11(12):e43741. PubMed ID: 36512386
[TBL] [Abstract][Full Text] [Related]
6. Tactical Considerations for Designing Real-World Studies: Fit-for-Purpose Designs That Bridge Research and Practice.
Dreyer NA; Mack CD
Pragmat Obs Res; 2023; 14():101-110. PubMed ID: 37786592
[TBL] [Abstract][Full Text] [Related]
7. Real-World Evidence-Current Developments and Perspectives.
Schad F; Thronicke A
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011793
[TBL] [Abstract][Full Text] [Related]
8. Clinical Pharmacology Applications of Real-World Data and Real-World Evidence in Drug Development and Approval-An Industry Perspective.
Zhu R; Vora B; Menon S; Younis I; Dwivedi G; Meng Z; Datta-Mannan A; Manchandani P; Nayak S; Tammara BK; Garhyan P; Iqbal S; Dagenais S; Chanu P; Mukherjee A; Ghobadi C;
Clin Pharmacol Ther; 2023 Oct; 114(4):751-767. PubMed ID: 37393555
[TBL] [Abstract][Full Text] [Related]
9. Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan.
Hiramatsu K; Barrett A; Miyata Y;
Drugs Real World Outcomes; 2021 Dec; 8(4):459-480. PubMed ID: 34148219
[TBL] [Abstract][Full Text] [Related]
10. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
Webster J; Smith BD
Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
[TBL] [Abstract][Full Text] [Related]
11. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
[TBL] [Abstract][Full Text] [Related]
12. The Expanding Role of Real-World Evidence Trials in Health Care Decision Making.
Klonoff DC
J Diabetes Sci Technol; 2020 Jan; 14(1):174-179. PubMed ID: 30841738
[TBL] [Abstract][Full Text] [Related]
13. The role of Real-World Data and evidence in oncology medicines approved in EU in 2018-2019.
Eskola SM; Leufkens HGM; Bate A; De Bruin ML; Gardarsdottir H
J Cancer Policy; 2023 Jun; 36():100424. PubMed ID: 37116794
[TBL] [Abstract][Full Text] [Related]
14. Real world evidence: An Indian perspective.
Dang A; Vallish BN
Perspect Clin Res; 2016; 7(4):156-160. PubMed ID: 27843789
[TBL] [Abstract][Full Text] [Related]
15. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
Wu J; Wang C; Toh S; Pisa FE; Bauer L
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
[TBL] [Abstract][Full Text] [Related]
16. Digital Health and Big Data Analytics: Implications of Real-World Evidence for Clinicians and Policymakers.
Magalhães T; Dinis-Oliveira RJ; Taveira-Gomes T
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886214
[TBL] [Abstract][Full Text] [Related]
17. Trial designs using real-world data: The changing landscape of the regulatory approval process.
Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
[TBL] [Abstract][Full Text] [Related]
18. Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications.
Zou KH; Li JZ; Imperato J; Potkar CN; Sethi N; Edwards J; Ray A
J Multidiscip Healthc; 2020; 13():671-679. PubMed ID: 32801731
[TBL] [Abstract][Full Text] [Related]
19. From real world data to real world evidence to improve outcomes in neuro-ophthalmology.
Colman BD; Zhu Z; Qi Z; van der Walt A
Eye (Lond); 2024 Jun; ():. PubMed ID: 38844583
[TBL] [Abstract][Full Text] [Related]
20. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
